Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)

Jurisdiction:
Federal
Incentive Type: Grant Program
Industries:
Medical, Technology,
Health And Safety, Food
Eligible Sector:
Business
Category:
Financial Incentive
Time Period:
FY 2015
Governing Body: National Institutes of Health
What’s it worth?: $2,500,000

The Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring program was designed to fund the development of cutting edge technologies designed to be used for long-term, automated, wearable, glucose regulation. Ideal projects include:

  • Glucose sensors and pancreatic hormones delivery systems
  • Algorithms and Integrated Systems
  • Pre-Clinical and Clinical research trials

There are three types of applications allowed: New proposals (Phase I), Renewal grants (Phase II) and Resubmission applications. Typical award amounts of not more than $225,000 for Phase I projects and up to $1,500,000 for Phase II projects with project duration of up to two years. All applicants must meet the following criteria: